These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 23084592)

  • 1. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
    Fanoe S; Hvidt C; Ege P; Jensen GB
    Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de pointes with methadone.
    Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone and the QT interval: relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone.
    Skjervold B; Bathen J; Spigset O
    J Clin Psychopharmacol; 2006 Dec; 26(6):687-9. PubMed ID: 17110841
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
    Athanasos P; Farquharson AL; Compton P; Psaltis P; Hay J
    J Addict Dis; 2008; 27(3):31-5. PubMed ID: 18956527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onsite QTc interval screening for patients in methadone maintenance treatment.
    Fareed A; Vayalapalli S; Byrd-Sellers J; Casarella J; Drexler K; Amar R; Smith-Cox J; Lutchman TS
    J Addict Dis; 2010 Jan; 29(1):15-22. PubMed ID: 20390695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization].
    Krook AL; Waal H; Hansteen V
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
    Kao DP; Haigney MC; Mehler PS; Krantz MJ
    Addiction; 2015 Sep; 110(9):1468-75. PubMed ID: 26075588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc interval prolongation in patients on long-term methadone maintenance therapy.
    Maremmani I; Pacini M; Cesaroni C; Lovrecic M; Perugi G; Tagliamonte A
    Eur Addict Res; 2005; 11(1):44-9. PubMed ID: 15608471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
    Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M
    Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.